Ingelheim, Germany and Oxford and London, UK, January 12th, 2021 – Boehringer Ingelheim and Enara Bio, today announced that they have entered into a strategic collaboration and licensing agreement to research…
Read More
Novel self-labelling mammalian display method for identifying antibodies against membrane proteins in their native configuration Paper published in Journal of Biological Chemistry demonstrates compatibility with downstream manufacturing technologies to help accelerate CAR-T…
Funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 January 2021) Immunocore,…
Exscientia, the world-leading artificial intelligence (AI) driven Pharmatech company, today announces the opening of its US based Miami office, with recruitment starting immediately. Led by Chief Research Engineer, Adrian Schreyer, Exscientia are recruiting…
Oxford, UK – Vaccitech Ltd announces that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in…
Oxford and London, UK – 9th December 2020. Enara Bio, a biotechnology company leveraging its proprietary T-cell/T-cell receptor (TCR) discovery and Dark Antigen™ platforms to deliver targeted cancer immunotherapies, announces…